US Cell Line Development Market Growth Outlook: Unlocking a US$ 18.62 Billion Opportunity by 2031
The United States represents the largest share of the Cell Line Development Market, driven by its strong biopharmaceutical industry, extensive research infrastructure, and significant investments in biotechnology innovation. The country is home to numerous leading pharmaceutical and biotechnology companies actively engaged in the development of monoclonal antibodies, recombinant proteins, cell...
0 Σχόλια 0 Μοιράστηκε 8 Views 0 Προεπισκόπηση